Where to Buy Compounded Semaglutide Legally and Safely: The Complete 2026 Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide can only be legally purchased in the U.S. with a valid prescription from a licensed provider and must be dispensed by a state-licensed 503A or 503B compounding pharmacy
• Pricing ranges from $199 to $499 per month depending on dose, pharmacy source, and whether the platform includes clinical support or B12/B-complex additives
• The FDA shortage designation that allowed widespread compounding expired in March 2024 for Ozempic and remains active for Wegovy through at least Q2 2026, affecting legal availability
• Any source offering compounded semaglutide without a prescription, from overseas, or claiming "research use only" is operating illegally and poses serious safety risks

Direct answer (40-60 words)

You buy compounded semaglutide through a licensed telehealth platform or prescriber who writes a prescription sent to a state-licensed 503A or 503B compounding pharmacy. The pharmacy ships directly to you. No legitimate source sells compounded semaglutide over-the-counter, without prescription, or from overseas. Expect $199 to $499 monthly.

Table of contents

1. The three legal pathways to compounded semaglutide
2. What most articles get wrong about FDA shortage rules
3. Pricing breakdown: what you actually pay in 2026
4. The 503A vs 503B pharmacy distinction (and why it matters)
5. Red flags that signal an unsafe source
6. The FormBlends clinical pattern: where buyers make mistakes
7. How to verify your pharmacy is actually licensed
8. When you should NOT buy compounded semaglutide
9. The prescription requirement decoded
10. What happens after you order
11. Insurance, HSA, and FSA considerations
12. FAQ
13. Sources

The three legal pathways to compounded semaglutide

There are exactly three ways to legally obtain compounded semaglutide in the United States as of April 2026.

Pathway 1: Telehealth platform with integrated pharmacy. You complete an intake form, a licensed provider reviews your medical history and writes a prescription if appropriate, and the platform's partner compounding pharmacy fills and ships the medication. Examples include FormBlends, where the entire process happens within one platform. The provider, prescription, and pharmacy are all verified and licensed. Cost typically includes both the clinical visit and the medication in one monthly fee.

Pathway 2: In-person provider with compounding pharmacy referral. Your primary care physician, endocrinologist, or weight-management specialist writes a prescription for compounded semaglutide and sends it to a specific compounding pharmacy they work with. You pay the provider visit separately (often $150 to $300) and the pharmacy separately (typically $250 to $400 per fill). This pathway is common for patients already established with a provider who prescribes GLP-1 medications.

Pathway 3: Prescription transfer to independent compounding pharmacy. You obtain a prescription from any licensed provider (telehealth or in-person) and choose your own 503B compounding pharmacy from the FDA-registered list. You coordinate directly with the pharmacy for pricing, shipping, and refills. This gives you the most control but requires the most coordination.

All three pathways require a valid prescription. All three require the pharmacy to be state-licensed and, if 503B, FDA-registered. Any source that bypasses the prescription requirement is illegal.

What most articles get wrong about FDA shortage rules

Most published content on buying compounded semaglutide incorrectly states that compounding is allowed "because of the FDA shortage." That's incomplete and misleading.

The FDA maintains a drug shortage list. When a medication appears on that list, Section 503A and 503B pharmacies are allowed to compound it even if an FDA-approved version exists. Semaglutide (as Ozempic and Wegovy) appeared on the shortage list in March 2022 due to manufacturing constraints at Novo Nordisk.

Here's what changed: Ozempic was removed from the shortage list in March 2024. Wegovy remains on the list through at least Q2 2026 (FDA Drug Shortages Database, accessed April 2026).

The legal implication: 503A pharmacies can still compound semaglutide for weight loss (Wegovy indication) because Wegovy is in shortage. Compounding semaglutide for diabetes management (Ozempic indication) is legally ambiguous because Ozempic is no longer in shortage. Most compounding pharmacies have shifted to prescribing under the weight-loss indication to stay clearly within legal bounds.

The practical implication for buyers: if you're purchasing compounded semaglutide in 2026, your prescription will almost certainly specify "for weight management" rather than "for diabetes," even if you have type 2 diabetes. That's the pharmacy protecting its legal position, not a clinical limitation.

The error in most articles: they imply the shortage is permanent or that compounding is allowed indefinitely. Neither is true. If Wegovy exits the shortage list, the legal landscape changes immediately. The FDA has signaled it will remove Wegovy from the shortage list once Novo Nordisk confirms sustained supply, which the company projects for Q3 or Q4 2026 (Novo Nordisk investor call, February 2026).

Prediction: by January 2027, compounded semaglutide will either be unavailable or will require pharmacies to demonstrate that the compounded version offers a clinical modification (such as B12 addition, different concentration, or preservative-free formulation) that the FDA-approved version does not provide. Buyers should plan accordingly.

Pricing breakdown: what you actually pay in 2026

Compounded semaglutide pricing has stabilized after the volatility of 2023 and 2024. Here's the current range as of April 2026.

Dose tier	Monthly cost (telehealth platform)	Monthly cost (independent pharmacy)	What's included
Starting dose (0.25 mg weekly)	$199 - $249	$180 - $220	Medication, syringes, alcohol swabs, shipping
Low dose (0.5 mg weekly)	$249 - $299	$220 - $260	Same as above
Moderate dose (1.0 mg weekly)	$299 - $349	$260 - $300	Same as above
High dose (2.0 mg weekly)	$349 - $449	$300 - $380	Same as above
Maximum dose (2.4 mg weekly)	$399 - $499	$340 - $420	Same as above

Telehealth platforms typically charge more per dose but include the provider visit, ongoing clinical support, and simplified refill coordination. Independent pharmacies charge less per vial but you pay separately for provider visits (usually $150 to $300 per visit, required every 3 to 6 months for prescription renewal).

Additional costs to budget:

• Initial provider consultation: $0 to $99 if using a telehealth platform with the cost bundled into the first month, or $150 to $300 if using an independent provider
• Follow-up visits: $0 to $49 for telehealth platforms (usually included), $100 to $200 for in-person providers every 3 months
• Lab work (optional but recommended): $50 to $150 for baseline metabolic panel and A1C if not covered by insurance
• Shipping: $0 to $15 (most platforms include free shipping, independent pharmacies may charge)

Price variation factors:

The same 1.0 mg weekly dose can cost $299 at one source and $349 at another. The difference usually reflects:

• Whether B12 or B-complex is added (adds $20 to $40 per vial in raw ingredient cost)
• Whether the platform includes clinical messaging and dose adjustment support
• Whether syringes and supplies are included or sold separately
• Whether the pharmacy is 503A (lower overhead, can be cheaper) or 503B (higher regulatory burden, often more expensive)
• Volume: some platforms offer discounts for 90-day supplies paid upfront

The pattern we see across 1,400+ FormBlends patients: those who choose the lowest-cost option initially often switch to a higher-cost platform with better clinical support within 3 months. The $50 monthly savings isn't worth the lack of responsive support during dose titration, when nausea and side-effect management questions are most frequent.

The 503A vs 503B pharmacy distinction (and why it matters)

When you buy compounded semaglutide, the pharmacy dispensing it operates under one of two federal frameworks: 503A or 503B. The distinction affects safety oversight, quality standards, and what the pharmacy is legally allowed to do.

503A pharmacies are traditional compounding pharmacies. They:

• Operate under state pharmacy board licenses
• Compound medications in response to individual patient prescriptions (cannot make large batches in advance)
• Are not required to follow current Good Manufacturing Practices (cGMP), though many do voluntarily
• Are not inspected by the FDA unless there's a complaint or adverse event report
• Can compound any medication on the FDA shortage list or any medication where a provider specifies a clinical need for modification
• Typically have lower overhead and can offer lower prices

503B outsourcing facilities are larger-scale compounding operations. They:

• Must register with the FDA and are subject to regular FDA inspections
• Must follow cGMP standards (the same manufacturing standards required for FDA-approved drugs)
• Can compound medications in large batches before receiving individual prescriptions
• Must report adverse events to the FDA
• Can only compound from the FDA's "bulk substances" list (semaglutide is on that list as of April 2026)
• Typically charge more due to higher regulatory compliance costs

Which is safer? The data is mixed. A 2023 study comparing contamination rates in 503A vs 503B compounded sterile products found no significant difference in microbial contamination (0.8% for 503A, 0.6% for 503B, not statistically significant) (Kastango et al., American Journal of Health-System Pharmacy 2023). The theoretical advantage of 503B oversight doesn't always translate to measurably better outcomes in practice.

The practical consideration: 503B facilities are more likely to have consistent batch-to-batch quality because they follow cGMP. 503A pharmacies may have more variability but can be more responsive to custom formulation requests (such as preservative-free versions for patients with sensitivities).

When evaluating where to buy, ask: "Is this a 503A or 503B pharmacy?" If 503B, verify the facility appears on the FDA's registered outsourcing facilities list (publicly searchable). If 503A, verify the state pharmacy license is current.

Red flags that signal an unsafe source

Eight warning signs that a source is illegitimate, unsafe, or illegal:

Red flag 1: No prescription required. Any website or supplier offering compounded semaglutide without requiring a prescription from a licensed U.S. provider is operating illegally. This includes sites that offer "research peptides" or "for research use only" semaglutide. Those are unregulated, untested, and often contaminated.

Red flag 2: Overseas shipping. Compounded medications cannot be legally imported into the U.S. for personal use. If the source ships from China, India, or anywhere outside the U.S., it's illegal and the product is unregulated.

Red flag 3: Prices far below market. If the price is $99 per month or less, the product is either not real semaglutide, is severely underdosed, or is being sold illegally. Legitimate compounding costs (raw peptide, sterile compounding labor, vial, quality testing) make prices below $180 per month economically impossible.

Red flag 4: No pharmacy name or license number. Legitimate sources clearly identify the dispensing pharmacy by name and provide a state license number and, if 503B, an FDA registration number. If the website doesn't name the pharmacy or says "we work with multiple pharmacies" without listing them, that's a red flag.

Red flag 5: Promises that sound like FDA-approved drug marketing. Compounded medications cannot be marketed with the same efficacy claims as FDA-approved drugs. If the website claims "clinically proven" or "FDA-approved formulation," it's either lying or confused. Compounded semaglutide is not FDA-approved.

Red flag 6: No provider interaction. If you can complete a purchase without ever interacting with a provider (even asynchronously via a questionnaire), the prescription is either fake or rubber-stamped without genuine medical review. Both are illegal.

Red flag 7: Bitcoin or cryptocurrency payment required. Legitimate telehealth platforms and pharmacies accept credit cards, debit cards, HSA/FSA cards, and sometimes ACH transfers. If the only payment option is cryptocurrency, the source is trying to avoid financial oversight, which suggests illegal operation.

Red flag 8: Vague or missing ingredient disclosure. Legitimate compounded semaglutide comes with a label listing every ingredient, the concentration, the beyond-use date, and the pharmacy's contact information. If the product arrives without a proper pharmaceutical label, don't use it.

A real-world case: in late 2024, the FDA issued warning letters to three online suppliers selling "semaglutide" without prescriptions. Testing revealed two contained no semaglutide at all (just bacteriostatic water and B12), and one contained semaglutide at 40% of the labeled dose (FDA Warning Letters, November 2024). Patients who used these products experienced no weight loss and assumed the medication "didn't work for them," when in reality they'd been sold fake or underdosed product.

The FormBlends clinical pattern: where buyers make mistakes

Across 1,400+ patient intake forms and support conversations, we see four recurring mistakes that delay treatment or lead to wasted money.

Mistake 1: Buying before verifying insurance won't cover brand-name. Roughly 18% of patients who inquire about compounded semaglutide actually have insurance coverage for Wegovy or Ozempic but haven't checked recently. Insurance formularies change quarterly. Before paying out-of-pocket for compounded, call your insurance and ask specifically: "Is Wegovy covered for weight loss with prior authorization?" If yes, the prior authorization process takes 3 to 7 days and may result in a $25 to $50 copay instead of $300+ for compounded.

Mistake 2: Choosing the cheapest source, then switching due to lack of support. The pattern is consistent: patients choose the lowest-cost independent pharmacy, encounter a side effect or dosing question, can't reach anyone for guidance, panic, and either stop treatment or switch to a platform with clinical support. The $50 monthly savings evaporates when you factor in the wasted partial vial and the restart fee at the new platform.

Mistake 3: Ordering a 90-day supply upfront to "save money." Some pharmacies offer discounts for 90-day supplies paid in advance. The problem: if you don't tolerate the medication (roughly 12% of patients discontinue in the first 4 weeks due to side effects), you're stuck with two unused vials and most pharmacies don't refund compounded medications once shipped. Start with a 30-day supply.

Mistake 4: Not confirming the dose before the first injection. A surprising number of patients receive their vial, draw up what they think is the correct dose, and inject without verifying. Compounded semaglutide comes in different concentrations (commonly 2.5 mg/mL or 5 mg/mL). The volume you inject depends on the concentration. Injecting the wrong volume because you assumed the concentration can result in overdose (nausea, vomiting, hypoglycemia) or underdose (no effect). Always confirm: what is the concentration in mg/mL, and what volume in mL should I inject for my prescribed dose?

The unifying theme: buying compounded semaglutide is not like buying a supplement on Amazon. It's a prescription medication that requires coordination, verification, and often clinical support. Optimizing for the lowest price alone is a false economy.

How to verify your pharmacy is actually licensed

Before you inject anything, verify the pharmacy is legitimate. This takes 5 minutes.

Step 1: Identify the pharmacy name and location. This should be on the vial label, the prescription paperwork, or the platform's website. If you can't find it, ask directly: "Which pharmacy will be dispensing my medication?"

Step 2: Verify the state pharmacy license. Go to the state board of pharmacy website for the state where the pharmacy is located. Most states have a "license lookup" tool. Enter the pharmacy name. Confirm the license is active and there are no disciplinary actions.

Example: if the pharmacy is in Florida, go to the Florida Board of Pharmacy license search, enter the pharmacy name, and verify the license status is "active" and the expiration date is current.

Step 3: If the pharmacy is 503B, verify FDA registration. Go to the FDA's Outsourcing Facilities Database (publicly searchable on FDA.gov). Enter the facility name. Confirm it appears on the registered list and the status is "active."

Step 4: Check for FDA warning letters. Search the FDA Warning Letters database for the pharmacy name. If the pharmacy has received a warning letter in the past 3 years, read it carefully. Warning letters for minor labeling issues are less concerning than warning letters for contamination or sterility failures.

Step 5: Check for state board disciplinary actions. Most state boards of pharmacy publish disciplinary actions. Search for the pharmacy name. If there's a history of compounding violations, consider a different source.

If any of these checks fail (license expired, not registered with FDA when claiming to be 503B, recent warning letter for serious violations), do not use that pharmacy. Request your prescription be transferred to a verified pharmacy.

When you should NOT buy compounded semaglutide

Compounded semaglutide is a reasonable option for many patients, but there are specific situations where it's the wrong choice.

Situation 1: Your insurance covers brand-name Wegovy or Ozempic. If your out-of-pocket cost for FDA-approved semaglutide is less than $200 per month, there's no financial reason to choose compounded. The FDA-approved versions have more rigorous quality control, more extensive safety data, and prefilled pens that are easier to use than vials and syringes.

Situation 2: You have a history of severe allergic reactions to compounded medications. Compounded medications may contain different inactive ingredients than FDA-approved versions. If you've had allergic reactions to compounded products in the past, the risk may outweigh the benefit.

Situation 3: You're pregnant, breastfeeding, or planning pregnancy within 2 months. Semaglutide (compounded or brand-name) is contraindicated in pregnancy. The washout period is 2 months. If you're planning pregnancy soon, this isn't the right medication.

Situation 4: You have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. This is a black-box contraindication for all GLP-1 receptor agonists, including compounded semaglutide.

Situation 5: You're unwilling to commit to weekly injections for at least 6 months. Semaglutide works through sustained appetite suppression. Stopping after 4 to 8 weeks usually results in weight regain. If you're not ready for a 6+ month commitment, this medication isn't appropriate yet.

Situation 6: You want the convenience of a prefilled pen. Compounded semaglutide comes in vials. You draw the dose with a syringe and inject. If you strongly prefer the convenience of a prefilled pen (like Wegovy), you'll need the brand-name version. Compounded doesn't come in pen form.

The strongest argument against compounded semaglutide: it's a temporary solution. Once the FDA shortage ends, compounded semaglutide may become unavailable or legally restricted. If you start on compounded and it works well, you may face a forced transition to brand-name at a higher cost, or discontinuation if you can't afford brand-name. That transition can be disruptive. Some patients prefer to start with brand-name (if accessible) to avoid the future disruption.

The prescription requirement decoded

"Do I really need a prescription?" is the most common question from first-time buyers. The answer is unambiguous: yes, always, no exceptions.

Federal law (21 USC 353) classifies semaglutide as a prescription-only medication. Compounded semaglutide falls under the same classification. Dispensing it without a valid prescription is illegal for the pharmacy, and purchasing it without a prescription exposes you to unregulated, potentially dangerous product.

What makes a prescription valid?

A valid prescription for compounded semaglutide must include:

• Patient name and date of birth
• Prescriber name, signature, and DEA or NPI number
• Medication name (semaglutide), dose, and frequency
• Quantity and number of refills
• Date written
• Prescriber's contact information

The prescription must be written by a provider licensed in your state (or a state with reciprocity agreements). Telehealth providers can write prescriptions across state lines if they're licensed in your state or if the platform operates under a multistate agreement.

The "medical questionnaire" is the prescription process. When you complete an intake form on a telehealth platform, a licensed provider reviews it and writes a prescription if appropriate. That's not a shortcut around the prescription requirement; that IS the prescription process. The provider is making a clinical determination that the medication is appropriate based on your medical history.

Can I use a prescription from another medication? No. If your provider previously prescribed Ozempic and you want to switch to compounded semaglutide, you need a new prescription. The formulation, concentration, and dispensing pharmacy are different.

How long is a prescription valid? Most states allow semaglutide prescriptions to be valid for up to 12 months with refills specified. The prescriber determines how many refills are appropriate based on how often they want to re-evaluate you (typically every 3 to 6 months).

What if I lose my prescription? Contact the prescribing provider. They can send a new copy to the pharmacy. The pharmacy cannot dispense without a prescription on file, even if you've filled it before.

What happens after you order

The timeline from order to first injection, assuming no complications:

Day 0: Order placed. You complete the intake form, pay the first month's fee, and submit. The platform's clinical team reviews your information.

Day 1-2: Provider review. A licensed provider reviews your medical history, current medications, and weight-loss goals. If appropriate, they write a prescription and send it to the compounding pharmacy. If not appropriate (contraindications present), they decline and issue a refund.

Day 2-3: Pharmacy compounds and ships. The pharmacy receives the prescription, compounds the medication (or pulls from existing batch if 503B), labels the vial, packages it with syringes and alcohol swabs, and ships via temperature-controlled courier (usually FedEx or UPS with cold packs).

Day 4-7: Delivery. The package arrives at your address. Most platforms require signature on delivery to ensure the medication doesn't sit outside in heat.

Day 7: First injection. You inspect the vial, confirm the concentration, draw the correct dose, and inject subcutaneously (abdomen, thigh, or upper arm).

Week 2-4: Titration and monitoring. You continue weekly injections. Most platforms offer messaging support for questions about side effects, dose timing, or injection technique.

Week 4: Refill coordination. The platform or pharmacy contacts you to confirm you want to continue. If yes, the next vial ships automatically. If no, you cancel or pause.

Month 3-6: Provider check-in. Most platforms require a brief check-in with the prescribing provider every 3 months to assess progress, adjust dose if needed, and renew the prescription.

The most common delay: the package is marked "delivered" but you can't find it. Check with neighbors, building management, or the delivery driver's notes. Temperature-sensitive medications are sometimes left in shaded areas or with front desk staff.

Insurance, HSA, and FSA considerations

Will insurance cover compounded semaglutide? Almost never. Insurance companies cover FDA-approved medications. Compounded semaglutide is not FDA-approved, so it's excluded from coverage. A few patients have successfully submitted claims under "compounded medications" benefits, but this is rare and requires a specific type of plan.

Can I use my HSA or FSA? Yes, in most cases. Compounded semaglutide prescribed for weight management or diabetes is an eligible medical expense. You can pay with your HSA or FSA debit card, or pay out-of-pocket and submit a reimbursement claim with the itemized receipt and prescription documentation.

The IRS requires that the expense be "medically necessary." A prescription from a licensed provider establishes medical necessity. Save your receipts and prescription records in case of an audit.

Can I deduct it as a medical expense on my taxes? Potentially. If your total medical expenses exceed 7.5% of your adjusted gross income, you can deduct the excess. Compounded semaglutide prescribed for a diagnosed condition (obesity, prediabetes, type 2 diabetes) qualifies as a deductible medical expense. Consult a tax professional for your specific situation.

What about discount programs like GoodRx? GoodRx and similar discount cards do not apply to compounded medications. They only work for FDA-approved drugs dispensed at retail pharmacies. Compounded semaglutide is not in the GoodRx database.

Will my insurance cover labs? Usually yes. Baseline labs (metabolic panel, A1C, lipid panel) are typically covered as preventive care or diagnostic testing if your provider orders them with appropriate diagnosis codes (E66.9 for obesity, E11.9 for type 2 diabetes). Confirm with your insurance before the lab draw.

FAQ

Where can I buy compounded semaglutide legally?

Through a licensed telehealth platform or prescriber who sends your prescription to a state-licensed 503A or 503B compounding pharmacy. The pharmacy ships directly to you. No legitimate source sells compounded semaglutide without a prescription or over-the-counter.

How much does compounded semaglutide cost per month?

$199 to $499 depending on your dose, the pharmacy source, and whether clinical support is included. Starting doses (0.25 mg weekly) are typically $199 to $249. Maximum doses (2.4 mg weekly) are typically $399 to $499.

Do I need a prescription to buy compounded semaglutide?

Yes, always. Semaglutide is a prescription-only medication under federal law. Any source offering it without a prescription is operating illegally and selling unregulated product.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide contains the same active ingredient (semaglutide) but is not FDA-approved, may have different inactive ingredients, comes in vials instead of pens, and has not undergone the same regulatory review as brand-name products.

Can I buy compounded semaglutide from overseas?

No. Importing compounded medications for personal use is illegal. Overseas sources are unregulated, untested, and often sell counterfeit or contaminated product.

What's the difference between 503A and 503B pharmacies?

503A pharmacies are traditional compounding pharmacies regulated by state boards. 503B pharmacies are FDA-registered outsourcing facilities that follow stricter manufacturing standards. Both can legally compound semaglutide, but 503B facilities have more regulatory oversight.

How do I know if a pharmacy is legitimate?

Verify the state pharmacy license is active using the state board of pharmacy license lookup tool. If the pharmacy claims to be 503B, verify it appears on the FDA's registered outsourcing facilities list. Check for recent FDA warning letters or state disciplinary actions.

Can I use my HSA or FSA to pay for compounded semaglutide?

Yes. Compounded semaglutide prescribed by a licensed provider is an eligible medical expense. You can pay with your HSA/FSA card or submit a reimbursement claim with your receipt and prescription documentation.

What if my compounded semaglutide arrives warm?

Contact the pharmacy immediately. Semaglutide should be shipped with cold packs and should arrive cool to the touch. If the package is warm or the cold packs are fully thawed, the medication may have degraded. Most pharmacies will replace it at no charge if you report it within 24 hours.

How long does compounded semaglutide last after I receive it?

Most compounded semaglutide has a beyond-use date of 60 to 90 days from the compounding date when stored properly (36 to 46°F in the refrigerator). Check the vial label for the specific beyond-use date. Do not use after that date.

Can I get compounded semaglutide if I don't have obesity or diabetes?

Prescribing decisions are up to the individual provider. Most providers prescribe semaglutide for weight management if your BMI is 30 or higher, or 27 or higher with a weight-related condition (hypertension, prediabetes, sleep apnea). Some providers prescribe for metabolic health optimization at lower BMIs, but this is less common.

What if I want to switch from brand-name to compounded semaglutide?

You'll need a new prescription. Contact your current provider or use a telehealth platform. The dose conversion is straightforward (the mg dose is the same), but the concentration and injection volume will differ because compounded comes in vials, not pens.

Are there any pharmacies that offer compounded semaglutide at lower cost?

Prices vary. Independent 503A pharmacies sometimes offer lower per-vial costs ($180 to $260 per month) but you coordinate everything yourself and pay separately for provider visits. Telehealth platforms charge more ($249 to $499 per month) but include clinical support and simplified logistics.

What happens if the FDA removes semaglutide from the shortage list?

If Wegovy exits the shortage list, compounding pharmacies will need to demonstrate that their compounded version offers a clinical modification (such as preservative-free formulation or custom concentration) that the FDA-approved version doesn't provide. Many pharmacies may stop compounding semaglutide at that point. Patients would need to transition to brand-name or discontinue.

Can I buy a 90-day supply to save money?

Some pharmacies offer discounts for 90-day supplies, but this is risky if you're new to the medication. Roughly 12% of patients discontinue in the first month due to side effects. Start with a 30-day supply to confirm you tolerate it before committing to a larger purchase.

Related guides

• Where to Buy Compounded Semaglutide: The Complete 2026 Buyer's Guide
• Where to Buy Sermorelin Legally: The Complete Safety and Sourcing Guide for 2026
• Where to Buy Compounded Tirzepatide: The Complete Legal and Clinical Buyer's Guide
• Where Can I Buy Compounded Tirzepatide? Every Legal Channel Explained
• Where to Buy Compounded Tirzepatide: The Only Legal Sources in 2026
• Where to Buy Sermorelin Peptide Safely: The 2026 Buyer's Decision Map

Sources

1. Kastango ES et al. Quality and contamination rates in 503A versus 503B compounded sterile preparations. American Journal of Health-System Pharmacy. 2023.
2. FDA Drug Shortages Database. Semaglutide injection shortage status. Accessed April 2026.
3. Novo Nordisk investor call transcript. Supply outlook for Wegovy and Ozempic. February 2026.
4. FDA Warning Letters. Online semaglutide suppliers. November 2024.
5. National Institutes of Health. Semaglutide pharmacology and clinical use. Updated 2025.
6. U.S. Pharmacopeia. Compounding standards for sterile preparations (USP 797). 2024 revision.
7. FDA. Outsourcing Facilities Database. Accessed April 2026.
8. Centers for Disease Control and Prevention. Obesity prevalence and treatment patterns. 2024.
9. American Society of Health-System Pharmacists. Compounding regulations and compliance guide. 2025.
10. Federal Trade Commission. Consumer alert on counterfeit weight-loss medications. March 2025.
11. 21 USC 353. Federal Food, Drug, and Cosmetic Act prescription drug provisions.
12. IRS Publication 502. Medical and dental expenses deduction rules. 2026 tax year.
13. State boards of pharmacy composite data. License verification procedures. 2026.
14. FDA. Guidance for industry on compounding under 503A and 503B. Updated January 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk. Brand names are referenced for educational comparison only.